Lam Research vs. KLA: Is Faster Growth Worth Paying More for Cash Flow?
Lam Research (LRCX) reported Q3 revenue of $6.72B, up 30% YoY, with strong margins. It grows faster than KLA (KLAC) but trades at a premium to free cash flow. LRCX has significant installed-base revenue and exposure to advanced chip manufacturing, while KLAC offers stronger historical cash returns. Both stocks rose in September, with KLAC up 7.3% and LRCX up 5.1%.
How this was made
The 30-second read
Why it matters
Provides a qualitative assessment of how the growth‑vs‑cash‑flow premium debate may influence investor positioning.
Market read
The article offers a comparative valuation view that may affect short‑term trading decisions in the semiconductor equipment space.
What to watch
Potential impact of export restrictions on Lam's China exposure.
Background
The piece compares Lam Research and KLA after Lam's recent earnings release, focusing on growth rates and valuation metrics.
Ticker impact
The article reports Lam Research's July 29 quarterly results, including $6.72 B revenue and $1.82 adjusted EPS.
potential pressure as investors weigh higher valuation against cash‑flow premium
Growth offsets premium, but valuation concerns may limit upside.
KLA is used as a peer comparison to Lam Research in the growth‑vs‑valuation discussion.
limited impact; serves mainly as a benchmark for Lam
No new company‑specific news, only comparative context.
Market effects
Highlights valuation trade‑off in semiconductor equipment sector.
Notes exposure to China, Taiwan, Korea which could affect regional demand.
Reinforces broader AI‑driven demand narrative for chip‑making tools.
Counterpoint
Investors may favor KLA's cash‑flow efficiency over Lam's growth premium.
Key entities
- companyLam Research Corporation
Semiconductor equipment maker reporting strong Q2 growth.
- companyKLA Corporation
Semiconductor equipment peer with slower growth but better cash‑flow multiples.
